Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S12-S18 , March 2004

Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension

References 

  1. The Advanced Glaucoma Intervention Study (AGIS) . 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429–440
  2. Abelson MB, Mroz M, Rosner SA. Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension. Adv Ther. 2003;20:1–13
  3. Brubaker RF. Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol. 2001;45(Suppl 4):S347–S351
  4. DuBiner H, Cooke D, Dirks M. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol. 2001;45(Suppl 4):S353–S360
  5. Gandolfi S, Simmons ST, Sturm R. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther. 2001;18:110–121
  6. Heijl A, Leske C, Bengtsson B. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120:1268–1279
  7. Higgenbotham E, Schuman J, Goldberg I. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol. 2002;120:1286–1293
  8. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 1991;111:51–55
  9. Netland PA, Landry T, Sullivan EK. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132:472–484
  10. Noecker RJ, Dirks MS, Choplin NT. A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol. 2003;135:55–63
  11. Orengo-Nania S, Landry T, Von Tress M. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. Am J Ophthalmol. 2001;132:860–868
  12. Parrish RK, Palmberg P, Sheu W-P. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003;135:688–703
  13. Sherwood M, Brandt J. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol. 2001;45(Suppl 4):S361–S368

☆ This study was sponsored by an unrestricted educational grant from Allergan, Inc., Irvine, CA. The authors have no proprietary interest in bimatoprost or Allergan, Inc.

PII: S0039-6257(03)00190-5

doi: 10.1016/j.survophthal.2003.12.015

Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S12-S18 , March 2004

Article Tools

* Image Usage & Resolution